| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard S. Kollender | Director | 2026-07-24 | 1,827 | $0.75 | $1.37kBuy |
| Richard S. Kollender | Director | 2026-07-24 | 1,681 | $0.75 | $1.26kBuy |
| Robert G. Spignesi Jr. | CEO;Pres | 2026-07-22 | 1,402 | $0.75 | $1.05kBuy |
| Sean M. Wirtjes | CHIEF FINANCIAL OFFICER | 2026-05-29 | 12,787 | $1.96 | $25.00kBuy |
| Inese Lowenstein | Director | 2026-05-29 | 12,787 | $1.96 | $25.00kBuy |
| Kirk Malloy | Director | 2026-05-29 | 12,787 | $1.96 | $25.00kBuy |
| Melinda Litherland Pei | Director | 2026-05-29 | 12,787 | $1.96 | $25.00kBuy |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2026-05-29 | 12,787 | $1.96 | $25.00kBuy |
| John J. Addington Wilson | CHIEF OPERATING OFFICER | 2026-03-11 | 9,603 | $4.32 | $41.47kSell |
| Sean M. Wirtjes | CHIEF FINANCIAL OFFICER | 2026-03-11 | 7,480 | $4.32 | $32.30kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jeffrey Lawrence Schwartz | 16.84% | 8,448,860 | $14.28M | Insider |
| Bain Capital Life Sciences Investors LLC | 16.82% | 8,434,560 | $14.25M | Insider |
| Bain Capital Life Sciences Investors LLC | 16.82% | 8,434,560 | $14.25M | Institution |
| Longitude Capital Partners II LLC | 8.16% | 4,093,159 | $6.92M | Insider |
| David Hirsch | 6.82% | 3,422,252 | $5.78M | Insider |
| Kennedy Lewis Management LP | 5.79% | 2,904,490 | $4.91M | Insider |
| Abgwtt Global Life Science Capital Partners GP Ltd | 3.68% | 1,848,296 | $3.12M | Institution |
| Richard S. Kollender | 3.22% | 1,614,835 | $2.73M | Insider |
| Robert G. Spignesi Jr. | 2.38% | 1,191,973 | $2.01M | Insider |
| Vanguard Capital Management LLC | 1.96% | 982,494 | $1.66M | Institution |